Moneycontrol
Get App
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 28, 16:00
277.70 -16.10 (-5.48%)
Volume
AVERAGE VOLUME
5-Day
121,862
10-Day
135,547
30-Day
92,299
102,764
  • Prev. Close

    293.80

  • Open Price

    288.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 28, 15:58
277.55 -16.20 (-5.51%)
Volume
AVERAGE VOLUME
5-Day
3,015,107
10-Day
3,134,763
30-Day
2,268,318
2,591,081
  • Prev. Close

    293.75

  • Open Price

    285.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    277.55 (8519)

Financials

2019 2018 2017 2016 2015
Nine Months Results of Glenmark Pharma (in Rs. Cr.) Dec '19 Dec '18 Dec '17 Dec '16 Dec '15  
Net Sales/Income from operations 5,104.90 4,600.38 4,589.73 5,756.27 4,187.47  
Other Operating Income -- 117.21 174.41 274.14 84.43  
Total Income From Operations 5,104.90 4,717.59 4,764.14 6,030.41 4,271.90  
EXPENDITURE  
Consumption of Raw Materials 1,702.34 1,330.96 1,507.31 1,694.14 1,258.30  
Purchase of Traded Goods 281.63 253.61 224.91 210.96 158.61  
Increase/Decrease in Stocks -3.12 154.93 17.11 -83.62 -111.00  
Power & Fuel -- -- -- -- --  
Employees Cost 829.93 745.75 789.59 693.35 536.23  
Depreciation 103.31 79.93 88.39 77.62 73.75  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 1,191.40 1,173.60 1,208.02 1,289.04 1,179.76  
P/L Before Other Inc. , Int., Excpt. Items & Tax 999.41 978.80 928.81 2,148.93 1,176.25  
Other Income 355.50 307.23 136.12 198.49 50.37  
P/L Before Int., Excpt. Items & Tax 1,354.91 1,286.02 1,064.93 2,347.42 1,226.62  
Interest 192.82 171.21 140.18 102.88 25.96  
P/L Before Exceptional Items & Tax 1,162.09 1,114.82 924.76 2,244.54 1,200.66  
Exceptional Items -- 345.19 -- -- --  
P/L Before Tax 1,162.09 1,460.00 924.76 2,244.54 1,200.66  
Tax 156.73 252.99 131.92 458.60 226.74  
P/L After Tax from Ordinary Activities 1,005.36 1,207.02 792.84 1,785.94 973.92  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- 133.81 -- -- --  
Net Profit/(Loss) For the Period 1,005.36 1,340.82 792.84 1,785.94 973.92  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 35.63 47.52 28.10 63.29 34.75  
Diluted EPS 35.63 47.52 28.09 63.28 34.74  
EPS After Extra Ordinary  
Basic EPS. 35.63 47.52 28.10 63.29 34.75  
Diluted EPS. 35.63 47.52 28.09 63.28 34.74  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited